Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07208162 · ClinicalTrials.gov registry record · NA

SHARE Adaptation Intervention for African-American Families

A NA study of Mild Dementia and Moderate Dementia, sponsored by Benjamin Rose Institute on Aging.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT07208162 is a NA study of Mild Dementia and Moderate Dementia that is actively recruiting participants, run by Benjamin Rose Institute on Aging. The registered enrollment target is 120 participants, above the 52-participant average among 5 other Mild Dementia trials with a reported enrollment target (131% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07208162, a NA study of Mild Dementia and Moderate Dementia, is actively recruiting participants, sponsored by Benjamin Rose Institute on Aging.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This project aims to culturally adapt the SHARE program for African-Americans in early-moderate stage dementia and their care partner. Upon completion of the adaptation, a pilot randomized-control trial wil be confucted to compare the adaptaed SHARE program versus usual care.

Interventions

  • BEHAVIORAL 5+1 Adapted, early-stage dyadic care planning intervention
  • BEHAVIORAL Counseling session and printed resources

Study Locations (1)

Ohio

  • Benjamin Rose - Cleveland

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-08-19
Est. Completion 2026-07
Phase NA

Sponsor

Benjamin Rose Institute on Aging

2 total trials

What the Registry Record Tells You About NCT07208162

The ClinicalTrials.gov registry entry for NCT07208162 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 52-participant average among 5 other Mild Dementia trials with a reported enrollment target (131% higher). The listed sponsor is Benjamin Rose Institute on Aging, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Dementia appearing as the primary indexed condition, and to 2 interventions - of which 5+1 Adapted, early-stage dyadic care planning intervention is the first listed.

NCT07208162 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT07208162 about?

NCT07208162 is a clinical study titled "SHARE Adaptation Intervention for African-American Families". This project aims to culturally adapt the SHARE program for African-Americans in early-moderate stage dementia and their care partner. Upon completion of the adaptation, a pilot randomized-control trial wil be confucted to compare the adaptaed SHARE program versus usual care.

What is the current status of trial NCT07208162?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-08-19. Estimated completion is 2026-07.

What conditions does trial NCT07208162 study?

This clinical trial studies the following conditions: Mild Dementia, Moderate Dementia.

What interventions are being tested in trial NCT07208162?

The interventions under investigation include: 5+1 Adapted, early-stage dyadic care planning intervention (BEHAVIORAL), Counseling session and printed resources (BEHAVIORAL).

Who is sponsoring clinical trial NCT07208162?

This trial is sponsored by Benjamin Rose Institute on Aging, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07208162 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.